Assyro AI

Orange Book product · Brand (NDA)

LEVITRA

VARDENAFIL HYDROCHLORIDE

Brand (NDA)NDA 021400DISCN BAYER HLTHCARE

At a glance

Aug 19, 2003

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 19, 2003

    23 yr 2 mo ago

  2. Today

  3. Patent 8273876 expires

    Listed method-of-use patent (U-1288) expiration.

    Jul 23, 2027

    in 1 yr 1 mo

Pharmaceutical detail

Active ingredient

VARDENAFIL HYDROCHLORIDE

Strength

EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 021400

Product number

003

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8273876Jul 23, 2027in 1 yr 1 mo
U-1288
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.